...
首页> 外文期刊>Journal of Cleaner Production >A mathematical model for pharmaceutical supply chain coordination: Reselling medicines in an alternative market
【24h】

A mathematical model for pharmaceutical supply chain coordination: Reselling medicines in an alternative market

机译:药物供应链协调的数学模型:替代市场中转售药物

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Leftover/end of life (EOL) medications not only cause financial losses for the pharmacy but also lead to disposal costs and high governmental penalties for the pharmaceutical supplier. In this study, a two-echelon pharmaceutical supply chain (PSC), including a single pharmaceutical supplier (pharma-supplier) and a single pharmaceutical retailer (pharmacy) with one type of fixed shelf-life medicine, is analyzed. A reducing pharmaceutical wastes scheme is developed to decrease relevant costs of leftover/EOL medicines, avoid governmental penalties, and also ensure patient service level (PSL). In the proposed model, excess medications are collected from the pharmacy warehouse based on the realized demand at a specific time before the expiration date to be resold in the secondary/alternative market. The introduced model is investigated in decentralized and centralized model structures. A novel combination of buyback and shortage risk-sharing contract (B&SRS) is proposed to attain channel coordination, maximize the whole PSC profits, and motivate members to participate in the scheme. The numerical investigation demonstrates that the proposed B&SRS contract can coordinate the developed PSC, enhance the whole channel profit, and also guarantee both channel members' profitability. Besides, the investigated model helps pharmaceutical managers to decrease EOL/expired medicines related costs and ensure PSL by making decision properly on buyback quantity. (c) 2020 Elsevier Ltd. All rights reserved.
机译:剩余/寿命结束(EOL)药物不仅导致药房的财务损失,而且还导致药物供应商处置和高政府处罚。在本研究中,分析了一个双梯级药物供应链(PSC),包括单一药品供应商(药物供应商)和一种具有一种固定保质期药物的单一药学零售商(药房)。减少药物废弃物计划是为了减少剩余/ EOL药物的相关成本,避免政府处罚,并确保患者服务水平(PSL)。在拟议的模型中,根据在次要/替代市场转售之前的特定时间,从药房仓库收集过量的药物。在分散和集中式模型结构中调查了介绍的模型。提出了一种新的回购和短缺风险共享合同(B&SRS)的结合,以获得渠道协调,最大限度地提高全部PSC利润,并激励成员参加该计划。数值调查表明,建议的B&SRS合同可以协调发达的PSC,增强整个渠道利润,并保证渠道成员的盈利能力。此外,调查模式有助于制药管理者通过在回购数量上正确做出决策来减少EOL /过期的药物相关成本并确保PSL。 (c)2020 elestvier有限公司保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号